Achilleas Gravanis, Professor of Pharmacology Medical School University of Crete. Researcher Institute of Molecular Biology & Biotechnology FORTH, Affiliated Research Professor Center of Drug Discovery Northeastern University Boston. He served as Member and Chairman of many research committees of the European Union, Member of the Fellowships Committee Federation European Biochemical Societies (FEBS). Co-founder of biotechnology spinoff Bionature Ltd, Collaborating Scientist, Emulate (Harvard spinoff). He has published more than 135 papers in PubMed (h-Index:44, citations: ~ 6.000). His research group is developing synthetic compounds, agonists of neurotrophin receptors, with neuroprotective and neurogenic properties and potential applications in therapeutics of neurodegenerative diseases. Additionally, his group is focusing on 3D microscaffold and neural stem cell technologies to develop neuroimplants for spinal cord injury and neurobiosensors for drug screening.
11:45 - 12:15
|State Of The Art 1 — Multidynamic Collagen-based Neuroimplants for Spinal Cord Injury||Multidynamic Collagen-based Neuroimplants for Spinal Cord Injury|